# Treatment of Opioid-refractory Pain (WHO Level III) by Pituitary Radiosurgery

> **NCT02637479** · NA · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 40 (estimated)

## Conditions studied

- Any Cancer With Multiple Bone Metastases

## Interventions

- **DEVICE:** GammaKnife®
- **DEVICE:** 18F-2-fluoro-2-deoxy-D-glucose - positron emission tomography (FDG-PET)
- **DEVICE:** MRI

## Key facts

- **NCT ID:** NCT02637479
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02637479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02637479, "Treatment of Opioid-refractory Pain (WHO Level III) by Pituitary Radiosurgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02637479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*